Organization
IRCCS San Raffaele
27 clinical trials
Clinical trial
The Role of Imaging Guided Surgery to Improve the Detection of Lymph Node Metastases in Prostate Cancer Patients Treated With Radical Prostatectomy and Extended Pelvic Lymph Node DissectionStatus: Recruiting, Estimated PCD: 2024-11-15
Clinical trial
Efficacy of Atazanavir / Ritonavir Monotherapy as Maintenance in Patients With Viral Suppression. Randomized, Open Label Non Inferiority Trial. A Phase 3 Study.Status: Completed, Estimated PCD: 2013-07-01
Clinical trial
Overnight Switch From Rasagiline To Safinamide In Fluctuating Patients With Parkinson's Disease: A Tolerability And Safety StudyStatus: Completed, Estimated PCD: 2019-03-31
Clinical trial
Open Label, Randomized (1:1) Clinical Trial to Evaluate Switching From Dual Regimens Based on Dolutegravir Plus a Reverse Transcriptase Inhibitor to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed, HIV-1 Infected Patients (Be-OnE Study).Status: Terminated, Estimated PCD: 2018-03-20
Clinical trial
Understanding Tumor and Immune Dynamics and Predicting Response to Various Perioperative Therapies in Patients With Muscle-invasive Bladder CancerStatus: Recruiting, Estimated PCD: 2026-03-15
Clinical trial
Use of Urinary Tumor Cells and Circulating Tumor Cells (CTCs) in the Prognosis and Therapy of Patients With Bladder (BCa) and Upper Urinary Tract (UTUC) Cancer"Status: Recruiting, Estimated PCD: 2025-09-29
Clinical trial
Analysis of Parathyroid Vascularization During Total Thyroidectomy Using Quantitative Real-time Indocyanine Green AngiographyStatus: Active (not recruiting), Estimated PCD: 2024-04-01
Clinical trial
EptinezuMaB in ReAl-world evidenCE: a 12-Months, Multicenter, Real-Life, Cohort Study in High-Frequency Episodic and Chronic Migraine (the EMBRACE Study)Status: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
A Prospective Phase II Single-Arm Trial on Neoadjuvant Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE Followed by Surgery for Resectable Pancreatic Neuroendocrine TumorsStatus: Completed, Estimated PCD: 2023-01-25
Clinical trial
Tolerability, Safety and Efficacy of Vortioxetine for Treatment od Depression in Parkinson's Disease: a 16 Week Open Label StudyStatus: Recruiting, Estimated PCD: 2023-07-30
Clinical trial
Discovering the Functional Role of the Glymphatic System in the Genesis of the Migraine AttackStatus: Recruiting, Estimated PCD: 2025-06-30
Clinical trial
Reduction of Progesterone Elevation at Trigger in Poor Responder Bologna' Criteria Patients After Controlled Ovarian Stimulation With Long Acting Standard Stimulation Protocol Compared With Conventional Daily Protocol: a Single Center Prospective Randomized Fase IV TrialStatus: Completed, Estimated PCD: 2024-01-19
Clinical trial
Retrospective Observational Comparison Study Between Ustekinumab and Tofacitinib as Third Line Therapy in a Multicenter Cohort of Patients With Refractory Ulcerative Colitis.Status: Completed, Estimated PCD: 2022-06-05
Clinical trial
Studio Osservazionale Retrospettivo Multicentrico Sull'Utilizzo di Ibrutinib in Monoterapia o in Associazione a Immunochemioterapia Secondo Schema R-CHOP in Pazienti Adulti Con Diagnosi di PCNSL Ricaduto o RefrattarioStatus: Recruiting, Estimated PCD: 2023-01-10
Clinical trial
Impact of Adalimumab Withdrawal or Continuation on Severity of COVID-19 and Risk of IMID RelapseStatus: Completed, Estimated PCD: 2022-10-31
Clinical trial
Phase II Prospective Monocentric Study on Prostate Cancer Restaging by Using PET/MR With Innovative RadiotracersStatus: Completed, Estimated PCD: 2022-10-05
Clinical trial
WEST-KOaST Study: WES (Whole Exome Sequencing) Analysis of Testicular Cancer Patientsand Their First-degree Family MembersStatus: Not yet recruiting, Estimated PCD: 2025-09-21
Clinical trial
EFFICACY AND SAFETY OF S.C. INFLIXIMAB IN PATIENTS SWITCHED FROM I.V. FORMULATION OF INFLIXIMABStatus: Recruiting, Estimated PCD: 2023-10-20
Clinical trial
Fully Hybrid 18F-PSMA PET/MRI as One-stop Approach for the Diagnosis of Clinically Significant Prostate CancerStatus: Not yet recruiting, Estimated PCD: 2025-07-31
Clinical trial
A Phase II Trial to Evaluate the Safety and Activity of Single-agent Lenalidomide Given as Maintenance Therapy After Response to Second-line Therapy in Patients With Relapsed DLBCL, Not Eligible for High-dose Chemotherapy and ASCT (Autologous Stem-Cell Transplantation)Status: Completed, Estimated PCD: 2017-03-01
Clinical trial
A Phase IIa Study to Assess the Safety, Tolerability, Plasma Pharmacokinetics and Efficacy of Intermittent Oral Administration of Standard Levodopa/Carbidopa vs. Semi-continuous Intra-oral Administration of Levodopa/Carbidopa in Patients With Advanced Parkinson's Disease Who Suffer Motor FluctuationsStatus: Completed, Estimated PCD: 2015-10-01
Clinical trial
Pilot Study for the Evaluation of the Parameters of Activity of a Preparation of PHGG and Sodium Hyaluronate in Chronic Constipation in Patients With Parkinson's DiseaseStatus: Completed, Estimated PCD: 2016-12-20
Clinical trial
Clinical and Pharmacokinetics Study to Evaluate the Therapeutic Equivalence and Bioequivalence of Levodopa Benserazide Generic Formulation (Teva Italia) Versus the Originator (Madopar®)Status: Completed, Estimated PCD: 2015-12-01
Clinical trial
Antiviral Long Acting Drugs Landing in People Living With HIV (ALADDIN): Prospective, Double-arm, Randomized, Open-label, Implementation-effectiveness Hybrid Type III StudyStatus: Not yet recruiting, Estimated PCD: 2026-03-01
Clinical trial
Prospective Monocentric Registry of Patients Undergoing Vitamin D Treatment at San Raffaele HospitalStatus: Not yet recruiting, Estimated PCD: 2029-12-01
Clinical trial
Oncotype DX in BRCA-mutated Breast Cancer Patients: Our Experience. A Retrospective Observational Monocentric StudyStatus: Completed, Estimated PCD: 2021-12-31
Clinical trial
Phase II Monocentric Study to Evaluate a Novel Approach for Staging Prostate Cancer Patients by Using a Fully Integrated Hybrid PET/MRIStatus: Recruiting, Estimated PCD: 2025-09-30